ZEVRA THERAPEUTICS, INC. Research And Development Expense

Quick Answer

ZEVRA THERAPEUTICS, INC. reported Research And Development Expense of $10.16 million for the year ending 2021.

  • ZEVRA THERAPEUTICS, INC. showed an increase of +14.9% in Research And Development Expense from 2020 to 2021.
  • This data is from ZEVRA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2022.
  • XBRL data for this metric is available from 2013 to 2021 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 9 years of available data (2013 to 2021), ZEVRA THERAPEUTICS, INC.'s Research And Development Expense has grown by 201.8%.
  • Historical annual values: Fiscal year 2021: $10.16 million | Fiscal year 2020: $8.84 million | Fiscal year 2019: $19.42 million | Fiscal year 2018: $41.76 million | Fiscal year 2017: $20.59 million | Fiscal year 2016: $20.47 million | Fiscal year 2015: $13.93 million | Fiscal year 2014: $11.92 million | Fiscal year 2013: $3.37 million.
  • Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: